-
1
-
-
84863707351
-
Cancer treatment and survivorship statistics, 2012
-
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, et al. Cancer treatment and survivorship statistics, 2012. CA: a cancer journal for clinicians. 2012; 62(4):220-241.
-
(2012)
CA: a cancer journal for clinicians
, vol.62
, Issue.4
, pp. 220-241
-
-
Siegel, R.1
DeSantis, C.2
Virgo, K.3
Stein, K.4
Mariotto, A.5
Smith, T.6
Cooper, D.7
Gansler, T.8
Lerro, C.9
Fedewa, S.10
Lin, C.11
Leach, C.12
Cannady, R.S.13
Cho, H.14
Scoppa, S.15
Hachey, M.16
-
3
-
-
42949126281
-
The current state of preclinical prostate cancer animal models
-
Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, VanDyke TA, Weber MJ, Wu L, et al. The current state of preclinical prostate cancer animal models. The Prostate. 2008; 68(6):629-639.
-
(2008)
The Prostate
, vol.68
, Issue.6
, pp. 629-639
-
-
Pienta, K.J.1
Abate-Shen, C.2
Agus, D.B.3
Attar, R.M.4
Chung, L.W.5
Greenberg, N.M.6
Hahn, W.C.7
Isaacs, J.T.8
Navone, N.M.9
Peehl, D.M.10
Simons, J.W.11
Solit, D.B.12
Soule, H.R.13
VanDyke, T.A.14
Weber, M.J.15
Wu, L.16
-
4
-
-
0141569009
-
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
-
Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV and Sawyers CL. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell. 2003; 4(3):223-238.
-
(2003)
Cancer Cell
, vol.4
, Issue.3
, pp. 223-238
-
-
Ellwood-Yen, K.1
Graeber, T.G.2
Wongvipat, J.3
Iruela-Arispe, M.L.4
Zhang, J.5
Matusik, R.6
Thomas, G.V.7
Sawyers, C.L.8
-
5
-
-
28844470357
-
Context-dependent hormonerefractory progression revealed through characterization of a novel murine prostate cancer cell line
-
Watson PA, Ellwood-Yen K, King JC, Wongvipat J, Lebeau MM and Sawyers CL. Context-dependent hormonerefractory progression revealed through characterization of a novel murine prostate cancer cell line. Cancer Res. 2005; 65(24):11565-11571.
-
(2005)
Cancer Res
, vol.65
, Issue.24
, pp. 11565-11571
-
-
Watson, P.A.1
Ellwood-Yen, K.2
King, J.C.3
Wongvipat, J.4
Lebeau, M.M.5
Sawyers, C.L.6
-
6
-
-
84858745800
-
Development of a castrate resistant transplant tumor model of prostate cancer
-
Ellis L, Lehet K, Ramakrishnan S, Adelaiye R and Pili R. Development of a castrate resistant transplant tumor model of prostate cancer. Prostate. 2012; 72(6):587-591.
-
(2012)
Prostate
, vol.72
, Issue.6
, pp. 587-591
-
-
Ellis, L.1
Lehet, K.2
Ramakrishnan, S.3
Adelaiye, R.4
Pili, R.5
-
7
-
-
80455131358
-
Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression
-
Ellis L, Lehet K, Ramakrishnan S, Adelaiye R, Miles KM, Wang D, Liu S, Atadja P, Carducci MA and Pili R. Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression. PloS one. 2011; 6(11):e27178.
-
(2011)
PloS one
, vol.6
, Issue.11
-
-
Ellis, L.1
Lehet, K.2
Ramakrishnan, S.3
Adelaiye, R.4
Miles, K.M.5
Wang, D.6
Liu, S.7
Atadja, P.8
Carducci, M.A.9
Pili, R.10
-
8
-
-
0029064248
-
The role of the diaphragm in lymphatic absorption from the peritoneal cavity
-
Abu-Hijleh MF, Habbal OA and Moqattash ST. The role of the diaphragm in lymphatic absorption from the peritoneal cavity. Journal of anatomy. 1995; 186 ( Pt 3):453-467.
-
(1995)
Journal of anatomy
, vol.186
, pp. 453-467
-
-
Abu-Hijleh, M.F.1
Habbal, O.A.2
Moqattash, S.T.3
|